These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
583 related articles for article (PubMed ID: 15630843)
21. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients. Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488 [TBL] [Abstract][Full Text] [Related]
22. A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution. Martinez AA; Gonzalez JA; Chung AK; Kestin LL; Balasubramaniam M; Diokno AC; Ziaja EL; Brabbins DS; Vicini FA Cancer; 2000 Jan; 88(2):425-32. PubMed ID: 10640977 [TBL] [Abstract][Full Text] [Related]
23. Very Early Salvage Radiotherapy Improves Distant Metastasis-Free Survival. Abugharib A; Jackson WC; Tumati V; Dess RT; Lee JY; Zhao SG; Soliman M; Zumsteg ZS; Mehra R; Feng FY; Morgan TM; Desai N; Spratt DE J Urol; 2017 Mar; 197(3 Pt 1):662-668. PubMed ID: 27614333 [TBL] [Abstract][Full Text] [Related]
24. Salvage radiotherapy for biochemical relapse after complete PSA response following radical prostatectomy: outcome and prognostic factors for patients who have never received hormonal therapy. Jacinto AA; Fede AB; Fagundes LA; Salvajoli JV; Castilho MS; Viani GA; Fogaroli RC; Novaes PE; Pellizzon AC; Maia MA; Ferrigno R Radiat Oncol; 2007 Feb; 2():8. PubMed ID: 17316430 [TBL] [Abstract][Full Text] [Related]
25. Management of biochemical failure following radical prostatectomy: salvage radiotherapy - a case series. Stockdale AD; Vakkalanka BK; Fahmy A; Desai K; Blacklock AR Prostate Cancer Prostatic Dis; 2007; 10(2):205-9. PubMed ID: 17310262 [TBL] [Abstract][Full Text] [Related]
26. Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. Catton C; Gospodarowicz M; Warde P; Panzarella T; Catton P; McLean M; Milosevic M Radiother Oncol; 2001 Apr; 59(1):51-60. PubMed ID: 11295206 [TBL] [Abstract][Full Text] [Related]
27. Serum PSA evaluations during salvage radiotherapy for post-prostatectomy biochemical failures as prognosticators for treatment outcomes. Do T; Dave G; Parker R; Kagan AR Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1220-5. PubMed ID: 11483332 [TBL] [Abstract][Full Text] [Related]
28. Prognostic implications of immediate PSA response to early salvage radiotherapy. Turner I I RM; Yabes JG; Woldemichael E; Deutsch MM; Smith RP; Werner RS; Jacobs BL; Nelson JB Can J Urol; 2016 Dec; 23(6):8568-8575. PubMed ID: 27995853 [TBL] [Abstract][Full Text] [Related]
29. Salvage prostatic fossa radiation therapy for biochemical failure after radical prostatectomy: the Sheba experience. Kundel Y; Pfeffer R; Lauffer M; Ramon J; Catane R; Symon Z Isr Med Assoc J; 2004 Jun; 6(6):329-31. PubMed ID: 15214457 [TBL] [Abstract][Full Text] [Related]
30. (IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy. Choo R; Hruby G; Hong J; Bahk E; Hong E; Danjoux C; Morton G; DeBoer G Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):269-76. PubMed ID: 12023129 [TBL] [Abstract][Full Text] [Related]
34. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy. Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941 [TBL] [Abstract][Full Text] [Related]
35. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy. Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777 [TBL] [Abstract][Full Text] [Related]
36. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial. Carrie C; Hasbini A; de Laroche G; Richaud P; Guerif S; Latorzeff I; Supiot S; Bosset M; Lagrange JL; Beckendorf V; Lesaunier F; Dubray B; Wagner JP; N'Guyen TD; Suchaud JP; Créhange G; Barbier N; Habibian M; Ferlay C; Fourneret P; Ruffion A; Dussart S Lancet Oncol; 2016 Jun; 17(6):747-756. PubMed ID: 27160475 [TBL] [Abstract][Full Text] [Related]
37. Outcomes of salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. Lee EK; Mui WH; Chan AW; Tung Y; Wong FC Hong Kong Med J; 2018 Jun; 24(3):218-225. PubMed ID: 29807949 [TBL] [Abstract][Full Text] [Related]
38. Salvage radiotherapy for prostate-specific antigen relapse after radical prostatectomy for prostate cancer: a single-center experience. Yoshida T; Nakayama M; Suzuki O; Matsuzaki K; Kobayashi Y; Takeda K; Arai Y; Kakimoto K; Nishiyama K; Nishimura K Jpn J Clin Oncol; 2011 Aug; 41(8):1031-6. PubMed ID: 21693484 [TBL] [Abstract][Full Text] [Related]
39. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy. Eggener SE; Roehl KA; Smith ND; Antenor JA; Han M; Catalona WJ J Urol; 2005 Apr; 173(4):1150-5. PubMed ID: 15758725 [TBL] [Abstract][Full Text] [Related]
40. Salvage conformal radiotherapy for biochemical recurrent prostate cancer after radical prostatectomy. Monti CR; Nakamura RA; Ferrigno R; Rossi A; Kawakami NS; Trevisan FA Int Braz J Urol; 2006; 32(4):416-26; discussion 427. PubMed ID: 16953908 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]